Nanodrug-enhanced radiofrequency tumor ablation: Effect of micellar or liposomal carrier on drug delivery and treatment efficacy

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Moussa, Marwan ^a   Goldberg, S Nahum ^a,b   Kumar, Gaurav ^a   Sawant, Rupa R ^c   Levchenko, Tatyana ^c   Torchilin, Vladimir P ^c   Ahmed, Muneeb ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOSOME; MACROGOL 2000; NANOPARTICLE; PLACEBO; QUERCETIN; ANTINEOPLASTIC ANTIBIOTIC; MICELLE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL LINE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG TARGETING; DRUG TUMOR LEVEL; FEMALE; FLUORESCENCE ANALYSIS; MICELLE; MICELLIZATION; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; RADIOFREQUENCY ABLATION; RAT; RAT MODEL; TUMOR XENOGRAFT; ANIMAL; CATHETER ABLATION; CHEMORADIOTHERAPY; DRUG SCREENING; FISCHER 344 RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CATHETER ABLATION; CHEMORADIOTHERAPY; DOXORUBICIN; FEMALE; LIPOSOMES; MICELLES; NANOPARTICLES; PARTICLE SIZE; QUERCETIN; RATS, INBRED F344; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84939834891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102727     Document Type: Article

References (38)

1. Ahmed M, Brace CL, Lee FT Jr, Goldberg SN (2011) Principles of and advances in percutaneous ablation. Radiology 258: 351-369.
2. Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, et al. (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234: 961-967. (Pubitemid 40250844)
3. Sofocleous CT, Garg SK, Cohen P, Petre EN, Gonen M, et al. (2013) Ki 67 is an Independent Predictive Biomarker of Cancer Specific and Local Recurrence-Free Survival After Lung Tumor Ablation. Ann Surg Oncol.
4. Sofocleous CT, Nascimento RG, Petrovic LM, Klimstra DS, Gonen M, et al. (2008) Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology 249: 364-374.
5. Ahmed M, Monsky WE, Girnun G, Lukyanov A, D'Ippolito G, et al. (2003) Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Cancer Res 63: 6327-6333. (Pubitemid 37255180)
6. Goldberg SN, Kamel IR, Kruskal JB, Reynolds K, Monsky WL, et al. (2002) Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol 179: 93-101. (Pubitemid 34694817)
7. Head HW, Dodd GD 3rd, Bao A, Soundararajan A, Garcia-Rojas X, et al. (2010) Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors. Radiology 255: 405-414.
8. Ahmed M, Goldberg SN (2004) Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia 20: 781-802. (Pubitemid 39496856)
9. D'Ippolito G, Ahmed M, Girnun GD, Stuart KE, Kruskal JB, et al. (2003) Percutaneous tumor ablation: reduced tumor growth with combined radiofrequency ablation and liposomal doxorubicin in a rat breast tumor model. Radiology 228: 112-118. (Pubitemid 36736077)
10. Ahmed M, Lukyanov AN, Torchilin V, Tournier H, Schneider AN, et al. (2005) Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. J Vasc Interv Radiol 16: 1365-1371. (Pubitemid 41463995)
11. Poon RT, Borys N (2011) Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer. Future Oncol 7: 937-945.
12. Wood BJ, Poon RT, Locklin JK, Dreher MR, Ng KK, et al. (2012) Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol 23: 248-255 e247.
13. Yang W, Ahmed M, Elian M, Hady ES, Levchenko TS, et al. (2010) Do Liposomal Apoptotic Enhancers IncreaseTumor Coagulation and End-Point Survival in Percutaneous Radiofrequency Ablation of Tumors in a Rat Tumor Model? Radiology 257: 685-696.
14. Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, et al. (2011) Radiofrequency ablation combined with liposomal quercetin to increase tumor destruction by modulation of heat shock protein production in a small animal model. Int J Hyperthermia 27: 527-538.
15. Soundararajan A, Dodd GD 3rd, Bao A, Phillips WT, McManus LM, et al. (2011) Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. Radiology 261: 813-823.
16. Poff JA, Allen CT, Traughber B, Colunga A, Xie J, et al. (2008) Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology 248: 485-491.
17. Andriyanov AV, Koren E, Barenholz Y, Goldberg SN (2014) Therapeutic efficacy of combining PEGylated liposomal doxorubicin and Radiofrequency (RF) Ablation: Comparison between slow-releasing non thermo-sensitive and fast-releasing drug thermo-sensitive nano-liposomes. Plos One [in press].
18. Ahmed M, Moussa M, Goldberg SN (2012) Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation. Chem Phys Lipids.
19. Rapoport N (2012) Ultrasound-mediated micellar drug delivery. Int J Hyperthermia 28: 374-385.
20. Perche F, Torchilin VP (2012) Cancer cell spheroids as a model to evaluate chemotherapy protocols. Cancer Biol Ther 13: 1205-1213.
21. Solazzo S, Ahmed M, Schor-Bardach R, Yang W, Girnun G, et al. (2010) Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology 255: 62-74.
22. Yamazaki Y, Hasebe Y, Egawa K, Nose K, Kunimoto S, et al. (2006) Anthracyclines, small-molecule inhibitors of hypoxia-inducible factor-1 alpha activation. Biol Pharm Bull 29: 1999-2003. (Pubitemid 44510798)
23. Monsky WL, Kruskal JB, Lukyanov AN, Girnun GD, Ahmed M, et al. (2002) Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 224: 823-829. (Pubitemid 34919820)
24. Sawant RR, Torchilin VP (2011) Design and synthesis of novel functional lipid-based bioconjugates for drug delivery and other applications. Methods Mol Biol 751: 357-378.
25. Theriault JR, Adachi H, Calderwood SK (2006) Role of scavenger receptors in the binding and internalization of heat shock protein 70. J Immunol 177: 8604-8611. (Pubitemid 44893823)
26. de Smet M, Hijnen NM, Langereis S, Elevelt A, Heijman E, et al. (2013) Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin. Invest Radiol 48: 395-405.
27. Poon RT, Borys N (2009) Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 10: 333-343.
28. Hamano N, Negishi Y, Takatori K, Endo-Takahashi Y, Suzuki R, et al. (2014) Combination of Bubble Liposomes and High-Intensity Focused Ultrasound (HIFU) Enhanced Antitumor Effect by Tumor Ablation. Biol Pharm Bull 37: 174-177.
29. Tsukioka Y, Matsumura Y, Hamaguchi T, Koike H, Moriyasu F, et al. (2002) Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil). Jpn J Cancer Res 93: 1145-1153. (Pubitemid 35314960)
30. Weissig V, Whiteman KR, Torchilin VP (1998) Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm Res 15: 1552-1556. (Pubitemid 28465741)
31. Goldberg SN, Girnan GD, Lukyanov AN, Ahmed M, Monsky WL, et al. (2002) Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 222: 797-804. (Pubitemid 34215233)
32. Kong J, Kong J, Pan B, Ke S, Dong S, et al. (2012) Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1alpha/VEGFA. PLoS One 7: e37266.
33. Nijkamp MW, van der Bilt JD, de Bruijn MT, Molenaar IQ, Voest EE, et al. (2009) Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg 249: 814-823.
34. Nikfarjam M, Muralidharan V, Christophi C (2006) Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery 139: 73-81. (Pubitemid 41814435)
35. Gasselhuber A, Dreher MR, Partanen A, Yarmolenko PS, Woods D, et al. (2012) Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation. Int J Hyperthermia 28: 337-348.
36. Potter AJ, Gollahon KA, Palanca BJ, Harbert MJ, Choi YM, et al. (2002) Flow cytometric analysis of the cell cycle phase specificity of DNA damage induced by radiation, hydrogen peroxide and doxorubicin. Carcinogenesis 23: 389-401. (Pubitemid 34257618)
37. Lukyanov AN, Gao Z, Mazzola L, Torchilin VP (2002) Polyethylene glycoldiacyl-lipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharm Res 19: 1424-1429. (Pubitemid 35266545)
38. Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, et al. (2012) Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: Reduced tumor growth and increased animal endpoint survival in a small animal tumor model. J Control Release.